US EditionPublished • loading... • Updated
UK boosts pandemic readiness with new vaccine factory
The new Oxfordshire site can produce up to 100 million mRNA vaccine doses annually and will create around 150 skilled jobs, enhancing UK pandemic readiness and pharmaceutical innovation.
- On September 24, 2025, Moderna, Inc. opened the Moderna Innovation and Technology Centre at Harwell Science and Innovation Campus, the UK’s first onshore mRNA vaccine manufacturing facility.
- Moderna is investing more than �1 billion in UK research and development as part of a 10-year strategic partnership with the UK Government, promising to restore domestic vaccine manufacturing amid halted investments by four major pharmaceutical companies.
- The site can produce up to 100 million mRNA vaccine doses per year, expandable to 250 million in a pandemic, and houses clinical R&D laboratories creating around 150 highly skilled jobs.
- The centre strengthens the country's pandemic preparedness and supports the 100 Days Mission, with Health Secretary Wes Streeting and the Medicines and Healthcare products Regulatory Agency praising its operational readiness.
- The move positions Britain as a stronger life-sciences hub, with Britain’s life sciences sector valued at 100 billion and analysts estimating Moderna's expansion could add 78 billion by 2035.
Insights by Ground AI
13 Articles
13 Articles
Millions of vaccines to be made in Oxfordshire - Asian News from UK
State-of-the-art research centre promises millions of seasonal vaccines, pandemic preparedness, and a boost to Britain’s £100bn life sciences sector…reports Asian Lite News A new era of vaccine innovation has begun in Oxfordshire as pioneering US biotech company Moderna formally opened its Innovation and Technology Centre on Wednesday, marking one of the most significant investments in Britain’s life sciences sector in recent years. The £1 billi…
Coverage Details
Total News Sources13
Leaning Left2Leaning Right0Center3Last UpdatedBias Distribution60% Center
Bias Distribution
- 60% of the sources are Center
60% Center
L 40%
C 60%
Factuality
To view factuality data please Upgrade to Premium
